Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The periodic down regulation of Cyclin E gene expression from exit of mitosis to end of G1 is controlled by a deacetylase- and E2F-associated bipartite repressor element

Abstract

The expression of cyclin E and that of a few other bona fide cell cycle regulatory genes periodically oscillates every cycle in proliferating cells. Although numerous experiments have documented the role of E2F sites and E2F activities in the control of these genes as cells exit from G0 to move through the initial G1/S phase transition, almost nothing is known on the role of E2Fs during the subsequent cell cycles. Here we show that a variant E2F-site that is part of the Cyclin E Repressor Module (CERM) (Le Cam et al., 1999b) accounts for the periodic down regulation of the cyclin E promoter observed between the exit from mitosis until the mid/late G1 phase in exponentially cycling cells. This cell cycle-dependent repression correlates with the periodic binding of an atypical G1-specific high molecular weight p107-E2F complex (Cyclin E Repressor Complex: CERC2) that differs in both size and DNA binding behaviors from known p107-E2F complexes. Notably, affinity purified CERC2 displays a TSA-sensitive histone deacetylase activity and, consistent with this, derepression of the cyclin E promoter by trichostatin A depends on the CERM element. Altogether, this shows that the cell cycle-dependent control of cyclin E promoter in cycling cells is embroiled in acetylation pathways via the CERM-like E2F element.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Alitalo R . 1990 Leuk. Res. 14: 501–514

  • Bennett JD, Farlie PG, Watson RJ . 1996 Oncogene 13: 1073–1082

  • Botz J, Zerfass-Thome K, Spitkovsky D, Delius H, Vogt B, Eilers M, Hatzigeorgiou A, Jansen-Durr P . 1996 Mol. Cell. Biol. 16: 3401–3409

  • Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T . 1998 Nature 391: 597–601

  • Campanero MR, Armstrong M, Flemington E . 1999 Mol. Cell. Biol. 19: 8442–8450

  • Carmen AA, Rundlett SE, Grunstein M . 1996 J. Biol. Chem. 271: 15837–15844

  • DeGregori J, Kowalik T, Nevins JR . 1995 Mol. Cell. Biol. 15: 4215–4224

  • Donnellan R, Chetty R . 1999 FASEB. J. 13: 773–780

  • Duronio RJ, O'Farrel PH . 1995 Genes Dev. 9: 1456–1468

  • Duronio RJ, Bonnette PC, O'Farrel PH . 1998 Mol. Cell. Biol. 18: 141–151

  • Dyson N . 1998 Genes Dev. 12: 2245–2262

  • Emiliani S, Fischle W, Van Lint C, Al-Abed Y, Verdin E . 1998 Proc. Natl. Acad. Sci. USA 95: 2795–2800

  • Fajas L, Le Cam L, Polanowska J, Fabbrizio E, Servant N, Philips A, Carnac G, Sardet C . 2000 FEBS Lett. 471: 29–33

  • Ferreira R, Magnaghi-Jaulin L, Robin P, Harel-Bellan A, Trouche D . 1998 Proc. Natl. Acad. Sci. USA 95: 10493–10498

  • Geng Y, Ng Eaton E, Picon M, Roberts JM, Lundberg A, Gifford A, Sardet C, Weinberg RA . 1996 Oncogene 12: 1173–1180

  • Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC . 1999 Cell 98: 859–869

  • Herrera RE, Sah VP, Williams BO, Makela TP, Weinberg RA, Jacks T . 1996 Mol. Cell. Biol. 16: 2402–2407

  • Hinchcliffe EH, Li C, Thompson EA, Maller JL, Sluder G . 1999 Science 283: 851–854

  • Hua XH, Yan H, Newport J . 1997 J. Cell. Biol. 137: 183–192

  • Huet X, Rech J, Plet A, Vié A, Blanchard JM . 1996 Mol. Cell. Biol. 16: 3789–3798

  • Humbert PO, Verona R, Trimarchi JM, Rogers C, Dandapani S, Lees JA . 2000 Genes Dev. 14: 690–703

  • Hurford RK, Cobrinik R, Lee MH, Dyson N . 1997 Genes Dev. 11: 1447–1463

  • Keyomarsi K, Herliczek TW . 1997 Prog. Cell. Cycle Res. 3: 171–191

  • Kim YB, Lee KH, Sugita K, Yoshida M, Horinouchi S . 1999 Oncogene 18: 2461–2470

  • Krude T, Jackman M, Pines J, Laskey RA . 1997 Cell 88: 109–119

  • Krude T . 2000 J. Biol. Chem. 275: 13699–13707

  • Le Cam L, Polanowska J, Fabbrizio E, Fajas L, Sardet C . 1999a Biotechniques 36: 840–843

  • Le Cam L, Polanowska J, Geng Y, Fabbrizio E, Olivier M, Philips A, Ng Eaton E, Classon M, Sardet C . 1999b EMBO. J. 18: 1878–1890

  • Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS, Nevins JR . 1998 Genes Dev. 12: 2120–2130

  • Li F, Altieri DC . 1999 Cancer Res. 59: 3143–3151

  • Lucibello FC, Truss M, Zwicker J, Ehlert F, Beato M, Muller R . 1995 EMBO. J. 14: 132–142

  • Ma T, Van Tine BA, Wei Y, Garrett MD, Nelson D, Adams PD, Wang J, Qin J, Chow LT, Harper JW . 2000 Genes Dev. 14: 2298–2313

  • Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T . 2000 EMBO. J. 19: 662–671

  • Marzio G, Wagener C, Gutierrez MI, Cartwright P, Helin K, Giacca M . 2000 J. Biol. Chem. 275: 10887–10892

  • Merrill GF . 1998 Methods Cell. Biol. 57: 229–249

  • Moberg K, Starz MA, Lees JA . 1996 Mol. Cell. Biol. 16: 1436–1449

  • Nevins JR . 1998 Cell. Growth Differ. 9: 585–593

  • Nicolas E, Morales V, Magnaghi-Jaulin L, Harel-Bellan A, Richard-Foy H, Trouche D . 2000 J. Biol. Chem. 275: 9797–9804

  • Ng HH, Bird A . 2000 Trends Biochem. Sci. 25: 121–126

  • Ohtani K, DeGregori J, Nevins JR . 1995 Proc. Natl. Acad. Sci. USA 92: 12146–12150

  • Ohtani K, DeGregori J, Leone G, Herendeen DR, Kelly TJ, Nevins JR . 1996 Mol. Cell. Biol. 16: 6977–6984

  • Qian YW, Wang YC, Hollingsworth RE, Jones D, Ling N, Lee EY . 1993 Nature 364: 648–652

  • Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones P, Wolffe AP . 2000 Nat. Genet. 25: 338–342

  • Sambucetti LC, Fischer DD, Zabludoff S, Kwon PO, Chamberlin H, Trogani N, Xu H, Cohen D . 1999 J. Biol. Chem. 274: 34940–34947

  • Sandor V, Senderowicz A, Mertins S, Sackett D, Sausville E, Blagosklonny MV, Bates SE . 2000 Br. J. Cancer 83: 817–825

  • Sardet C, Le Cam L, Fabbrizio E, Vidal M . 1997 In Progress in Gene Expression, Oncogenes as Transcriptional Regulators, Karin M, Ghysdael J and Yaniv M (eds) Birkhauser Verlag Publisher: Basel, Swiss. Vol 2 pp. 1–62

  • Sherr CJ . 1996 Science 274: 1672–1677

  • Smith E, Leone G, DeGregori J, Jakoi L, Nevins JR . 1996 Mol. Cell. Biol. 16: 6965–6976

  • Spitkovsky D, Steiner P, Lukas J, Lees E, Pagano M, Schulze A, Joswig S, Picard D, Tommasino M, Eilers M, Jansen-Dürr P . 1994 J. Virol. 68: 2206–2214

  • Stiegler P, De Luca A, Bagella L, Giordano A . 1998 Cancer Res. 58: 5049–5052

  • Sudarsanam P, Winston F . 2000 Trends Genet. 16: 345–350

  • Takahashi Y, Rayman JB, Dynlacht BD . 2000 Genes Dev. 14: 804–816

  • Tommasi S, Pfeifer GP . 1995 Mol. Cell. Biol. 15: 6901–6913

  • Tommasi S, Pfeifer GP . 1999 J. Biol. Chem. 274: 27829–27838

  • Uchiumi T, Longo DL, Ferris DK . 1997 J. Biol. Chem. 272: 9166–9174

  • Vogt B, Zerfass-Thome K, Schulze A, Botz JW, Zwerschke W, Jansen-Durr P . 1999 J. Gen. Virol. 80: 2103–2113

  • Wells J, Held P, Illenye S, Heintz NH . 1996 Mol. Cell. Biol. 16: 634–647

  • Wells J, Boyd KE, Fry CJ, Bartley SM, Farnham PJ . 2000 Mol. Cell. Biol. 16: 5797–5807

  • Wolffe AP, Pruss D . 1996 Cell 84: 817–819

  • Wolffe AP, Urnov FD, Guschin D . 2000 Biochem. Soc. Trans. 28: 379–386

  • Zerfass K, Schulze A, Spitkovsky D, Friedman V, Henglein B, Jansen-Dur P . 1995 J. Virol. 69: 6389–6399

  • Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, Harbour JW, Dean DC . 2000 Cell 101: 79–89

  • Zhao J, Kennedy BK, Lawrence BD, Barbie DA, Matera AG, Fletcher JA, Harlow E . 2000 Genes Dev. 14: 2283–2289

  • Zwicker J, Lucibello FC, Wolfram LA, Gross C, Trus M, Engeland K, Müller R . 1995 EMBO J. 14: 4514–4522

  • Zwicker J, Liu NS, Engeland K, Lucibello FC, Muller R . 1996 Science 271: 5255–5254

  • Zwicker J, Muller R . 1997 Trends Genet. 1: 3–6

Download references

Acknowledgements

This work was funded by grants from the french CNRS (ATIPE n°3), from ‘l'Association pour la Recherche contre le Cancer (ARC)’, from ‘La Ligue Contre le Cancer’ and from the ‘Human Frontier in Science Program’. J Polanowska was supported by a Boehringer Ingelheim doctoral fellowship and L Le Cam by a predoctoral fellowship from La ligue Contre le Cancer. We are grateful to Dr E Schwob for precious help on developing centrifugal elutriation, Dr O Coux and F Martin for help to purify CERC, and to Dr C Murchardt and J De Caprio for reagents. We would like to express special thanks to B Hipskind, JM Blanchard, L Dirick and A Le Cam for critical reading of the manuscript.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Polanowska, J., Fabbrizio, E., Le Cam, L. et al. The periodic down regulation of Cyclin E gene expression from exit of mitosis to end of G1 is controlled by a deacetylase- and E2F-associated bipartite repressor element. Oncogene 20, 4115–4127 (2001). https://doi.org/10.1038/sj.onc.1204514

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204514

Keywords

This article is cited by

Search

Quick links